[Liebert]
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study
文献作者：Vivek Subbiah; Mimi I. Hu; Aaron S. Mansfield; Matthew H. Taylor; Martin Schuler; Viola W. Zhu; Julien Hadoux; Giuseppe Curigliano; Lori Wirth; Justin F. Gainor; Guzman Alonso; Douglas Adkins; Yann Godbert; Myung-Ju Ahn; Philippe A. Cassier; Byoung Chul Cho; Chia-Chi Lin; Alena Zalutskaya; Teresa Barata; Peter Trask; Astrid Scalori; Walter Bordogna; Sebastian Heinzmann; Marcia S. Brose
